- Report
- January 2024
- 102 Pages
From €3117EUR$3,450USD£2,665GBP
- Report
- January 2024
- 134 Pages
Europe
From €3117EUR$3,450USD£2,665GBP
- Report
- January 2024
- 120 Pages
Middle East, Africa
From €3117EUR$3,450USD£2,665GBP
- Report
- January 2024
- 167 Pages
Asia Pacific
From €3117EUR$3,450USD£2,665GBP
- Report
- September 2023
- 272 Pages
Global
From €4021EUR$4,450USD£3,438GBP
- Report
- May 2022
- 175 Pages
Global
From €4021EUR$4,450USD£3,438GBP
- Report
- April 2022
- 217 Pages
Global
From €4021EUR$4,450USD£3,438GBP
- Report
- January 2024
- 425 Pages
Global
From €3253EUR$3,600USD£2,781GBP
- Report
- March 2024
- 147 Pages
Global
From €3072EUR$3,400USD£2,626GBP
€3840EUR$4,250USD£3,283GBP
- Report
- January 2024
- 141 Pages
Global
From €3072EUR$3,400USD£2,626GBP
€3840EUR$4,250USD£3,283GBP
- Report
- December 2023
- 140 Pages
Global
From €3217EUR$3,560USD£2,750GBP
€4021EUR$4,450USD£3,438GBP
- Report
- November 2021
- 112 Pages
Global
From €3217EUR$3,560USD£2,750GBP
€4021EUR$4,450USD£3,438GBP
- Report
- April 2024
- 140 Pages
Global
From €4472EUR$4,949USD£3,823GBP
- Report
- December 2023
- 210 Pages
Global
From €3252EUR$3,599USD£2,780GBP
- Report
- May 2024
- 140 Pages
Global
From €4472EUR$4,949USD£3,823GBP
- Report
- February 2024
- 160 Pages
Global
From €4490EUR$4,969USD£3,839GBP
- Report
- February 2024
- 160 Pages
Global
From €4490EUR$4,969USD£3,839GBP
- Report
- September 2023
- 140 Pages
Global
From €3252EUR$3,599USD£2,780GBP
- Report
- July 2023
- 140 Pages
Global
From €4472EUR$4,949USD£3,823GBP
- Report
- July 2023
- 140 Pages
Global
From €4472EUR$4,949USD£3,823GBP

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species.
The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more